Clinical trial
HER2 Circulating Tumor Cells in Gastric Cancer
NCT01299688 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HER2 Circulating Tumor Cells in Gastric Cancer
- Lead sponsor
- Samsung Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 31, 2010
- Completion date
- March 11, 2013
- Enrollment
- 135 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer